Postoperative Gastrointestinal Dysfunction
5
1
1
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 47/100
20.0%
1 terminated out of 5 trials
66.7%
-19.8% vs benchmark
0%
0 trials in Phase 3/4
100%
2 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Effect of TAP Block on GI Function After Sleeve Gastrectomy Using PRO-diGI Scale and Perlas Score
A Phase Ⅱ Study of Mosapride Citrate Injection in the Treatment of Postoperative Gastrointestinal Dysfunction
External Application of Mirabilite to Promote Recovery in Patients After Gastrointestinal Surgery
A Study of TAK-954 to Treat Gastrointestinal Dysfunction in Adults After Surgery
A Study of Naldemedine in Participants Undergoing Surgeries That Include a Bowel Resection or Bowel Transection